Literature DB >> 16433946

Neuropsychological detection of cognitive impairment: inter-rater agreement and factors affecting clinical decision-making.

Holly A Tuokko1, Gillian Gabriel.   

Abstract

The agreement between neuropsychologists identifying cognitive impairment (CI) in older adults was examined, as were factors influencing the classification process. Twenty four neuropsychologists in 18 study centers classified cases with or without CI after reviewing neuropsychological findings and other relevant information. All cases were participants in the third wave of the Canadian Study of Health and Aging, a study of CI in later life. For 117 randomly selected cases, a second neuropsychologist reviewed the same material and reclassified the cases. Cases given the same (concordant) or different (discordant) classifications were compared with respect to patient and rater characteristics. The inter-rater agreement was moderate (77.7% agreement, kappa = .49). On all measures of cognitive functioning, the concordant group without impairment obtained a higher mean score than the discordant group, and the discordant group obtained a higher mean score than the concordant group with impairment. For 5 out of 8 cognitive measures, the concordant group with impairment differed from the concordant group without impairment and the discordant group, but the latter two groups did not differ significantly. The findings are comparable to others in the field and highlight the need for neuropsychologists to further clarify procedures for identifying subtle, or mild, forms of cognitive impairment.

Entities:  

Mesh:

Year:  2006        PMID: 16433946     DOI: 10.1017/S1355617706060103

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  1 in total

1.  Comparing a Single Clinician Versus a Multidisciplinary Consensus Conference Approach for Dementia Diagnostics.

Authors:  Gorm Thorlacius-Ussing; Marie Bruun; Le Gjerum; Kristian S Frederiksen; Hanneke F M Rhodius-Meester; Wiesje M van der Flier; Gunhild Waldemar; Steen G Hasselbalch
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.